MYALEPTA (metreleptin) Receives Positive CHMP Opinion in Patients with Generalized and Partial Lipodystrophy Pharmaceutical Investing
Sarepta Receives Negative CHMP Opinion for EXONDYS® (eteplirsen) to Treat Patients with Duchenne Muscular Dystrophy in Europe Pharmaceutical Investing
Oragenics Reports Positive Interim Safety Analysis Results from Its Phase 2 Clinical Trial of AG013 for Oral Mucositis Pharmaceutical Investing
Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression Biotech Investing
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018 Biotech Investing
Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts Cannabis Investing News
Clovis Oncology Announces European Commission Authorization of Rubraca (rucaparib) for Women with Recurrent Ovarian Cancer Pharmaceutical Investing
